Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Conditions
Sickle Cell Disease Vaso-occlusive Crisis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Univ. of California, San Francisco Health Care, Oakland, California, United States
University of California Irvine, Orange, California, United States
Contact: Study coordinator (Use Central Contact)Golisano Children's Hospital, Fort Myers, Florida, United States
Contact: Study coordinator (Use Central Contact)The Foundation for Sickle Cell Disease, Hollywood, Florida, United States
Contact: Study coordinator (Use Central Contact)University of Louisville Hospital, Louisville, Kentucky, United States
University of Maryland, Baltimore, Maryland, United States
Contact: Study coordinator (USE CENTRAL Contact)Detroit Medical Center, Detroit, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Contact: Study coordinator (Use Central Contact)Mount Sinai Medical Center, New York, New York, United States
Contact: Study coordinator (USE CENTRAL CONTACT)Jacobi Medical Center, The Bronx, New York, United States
Contact: Study coordinator (Central Contact)East Carolina University, Greenville, North Carolina, United States
University of Cincinnati, Cincinnati, Ohio, United States
Contact: Study coordinator (Use Central Contact)The Ohio State University, Columbus, Ohio, United States
Contact: Study coordinator (USE CENTRAL CONTACT)University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Hacettepe Universitesi, Ankara, Turkey (Türkiye)
Contact: Study coordinator (Central Contact)Istanbul Universitesi, Istanbul, Turkey (Türkiye)
Contact: Study coordinator (Central Contact)Özel Acibadem Adana Hastanesi, Seyhan, Turkey (Türkiye)
Contact: Study coordinator (Central Contact)
Study leads
Study Director
CSL Behring